Literature DB >> 1971589

Echocardiographic assessment of lack of beta 1-receptor down-regulation during prolonged therapy with xamoterol.

P Cheron1, M Nannan, H Pouleur, M F Rousseau.   

Abstract

The effects of xamoterol 0.2 mg kg-1 i.v. on haemodynamics at rest and on exercise were tested in eight patients, before and after 60 days regular treatment with 200 mg b.d. Left ventricular function improved equally with xamoterol on both occasions. Tachyphylaxis and beta-receptor down-regulation do not occur during xamoterol therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971589     DOI: 10.1093/eurheartj/11.suppl_a.46

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  1 in total

1.  Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers.

Authors:  R F Schäfers; I Karl; K Mennicke; A E Daul; T Philipp; O E Brodde
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.